CN105010579A - Tea oil special for diabetes patients and preparation method thereof - Google Patents
Tea oil special for diabetes patients and preparation method thereof Download PDFInfo
- Publication number
- CN105010579A CN105010579A CN201510487743.0A CN201510487743A CN105010579A CN 105010579 A CN105010579 A CN 105010579A CN 201510487743 A CN201510487743 A CN 201510487743A CN 105010579 A CN105010579 A CN 105010579A
- Authority
- CN
- China
- Prior art keywords
- parts
- oil
- raw material
- tea oil
- tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 49
- 239000010495 camellia oil Substances 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 49
- 239000003921 oil Substances 0.000 claims abstract description 24
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 11
- 241000251468 Actinopterygii Species 0.000 claims abstract description 10
- 244000000626 Daucus carota Species 0.000 claims abstract description 10
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 10
- 244000294611 Punica granatum Species 0.000 claims abstract description 10
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 10
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 10
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 10
- 240000006365 Vitis vinifera Species 0.000 claims abstract description 10
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 10
- 210000004185 liver Anatomy 0.000 claims abstract description 10
- 235000019198 oils Nutrition 0.000 claims description 23
- 239000000047 product Substances 0.000 claims description 20
- 239000008157 edible vegetable oil Substances 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 14
- 235000000832 Ayote Nutrition 0.000 claims description 10
- 240000004244 Cucurbita moschata Species 0.000 claims description 10
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 10
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 10
- 244000302512 Momordica charantia Species 0.000 claims description 10
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 10
- 235000018365 Momordica dioica Nutrition 0.000 claims description 10
- 244000269722 Thea sinensis Species 0.000 claims description 10
- 230000007935 neutral effect Effects 0.000 claims description 10
- 235000015136 pumpkin Nutrition 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 238000009938 salting Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 108091005804 Peptidases Proteins 0.000 claims description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000012267 brine Substances 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 238000002203 pretreatment Methods 0.000 claims description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 2
- 240000001548 Camellia japonica Species 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 235000018597 common camellia Nutrition 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 241000408747 Lepomis gibbosus Species 0.000 abstract 1
- 244000078912 Trichosanthes cucumerina Species 0.000 abstract 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 235000020236 pumpkin seed Nutrition 0.000 abstract 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 230000036772 blood pressure Effects 0.000 description 14
- 235000013616 tea Nutrition 0.000 description 14
- 230000000694 effects Effects 0.000 description 8
- 230000036541 health Effects 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 239000010461 other edible oil Substances 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000011149 active material Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000010718 Oxidation Activity Effects 0.000 description 1
- 206010057430 Retinal injury Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides tea oil special for diabetes patients and a preparation method thereof, and the preparation raw materials comprise camellia seeds: 5-8 parts, fish liver: 2-3 parts of black sesame: 2-3 parts of grape seeds: 1-2.5 parts of pumpkin seeds: 1-2 parts of pomegranate seeds: 0.5-1.5 parts, carrot: 0.5-1 part, bitter gourd: 0.5-1 part; the preparation method comprises the following steps: pretreating raw materials, performing microwave treatment on the raw materials, extracting the solution, performing enzymolysis treatment, and finally preparing the finished oil. The invention has comprehensive nutrition, is rich in unsaturated fatty acid and antioxidant substances, can remove free radicals in vivo, and is suitable for diabetics to eat.
Description
Technical field
The present invention relates to the edible oil that a kind of diabetes patient is special, specifically a kind of tea oil, belongs to food processing technology field.
Background technology
The epidemiology survey result display of the up-to-date diabetes that diabetology branch of Chinese Medical Association carries out in June, 2007-2008 year May in 14 provinces and cities in the whole nation, the illness rate of cities and towns diabetes reaches 11.28%, point out the illness rate of current China diabetes in higher level, with being on close level of medium-developed country.Estimate according to the World Health Organization (WHO), the whole world has more than 1.5 hundred million diabetics at present, to this numeral in 2025 by increase by 1 times, estimate that the existing diabetic of China is more than 4,000 ten thousand, occupies the 2nd, the world, diabetes are because of pathogenesis complexity, radical cure difficulty, except passing through oral hypoglycaemic medicine or insulin injection, daily life nursing is also very crucial, especially should be noted that diet.Medicine can bring glad tidings for diabetes patient in conjunction with the double treatment mode of diet.
Oil tea is the woody edible oil seeds that China's plantation history reaches more than 2300 year, and utilizing tea seed to squeeze the tea oil extracted is the edible oil that on the south China the Changjiang river, oil tea plantation Area Inhabitants is traditional.Tea oil has higher nutritive value and health care, be rich in monounsaturated fatty acids, its aliphatic acid proportion of composing is similar to universally acknowledged best olive oil, even more be better than olive oil, meet very much the needs of human body, and in polyunsaturated fatty acid, ω-6 and the ratio of ω-3 meet (6: 1 ~ 4: 1) of international trophic level.Also containing more V E, V D, V K, Tea Polyphenols and carotenoid in tea oil.
Tea oil has nutritive value and market potential as " east olive oil ", at present, existing multinomial patent of invention is the health-care effect for tea oil, tea oil as special in a kind of old man and preparation method thereof (CN 102805160 B), describe a kind of tea oil aiming at the elderly and make, a kind of special tea oil for pregnant women and processing technology (CN 102669305 B) thereof, camellia oil (CN 101305973 B) of baby skin protection etc., visible, the multiple efficacies effect of tea oil can more and more excavate by people, and will put goods on the market, to cater to the multi-level demand of consumer.
Summary of the invention
The object of this invention is to provide a kind of tea oil of diabetic patients, anti-oxidant, hypoglycemic, to fill up gaps in market.
For achieving the above object, the concrete technical scheme that the present invention takes is:
The tea oil that diabetes patient is special, is characterized in that being prepared from by following raw materials according:
Tea seed: 5-8 part, fish liver: 2-3 part, Semen sesami nigrum: 2-3 part, grape pip: 1-2.5 part, pumpkin: 1-2 part, pomegranate seed: 0.5-1.5 part, carrot: 0.5-1 part, balsam pear: 0.5-1 part;
Its preparation method is:
(1) raw material pre-treatment: selected respectively by above-mentioned raw materials, clear up removal of impurities and dry process, dry environment is that low-temperature dark is dry, and baking temperature is no more than 20 DEG C, and after dry, each material composition mixes and is crushed to Powdered, and particle diameter is not more than 0.15mm;
(2) raw material microwave process: by the above-mentioned raw material handled well, put into micro-wave oven microwave 90-110s, microwave frequency is set to 2450MHz;
(3) solution extracts: the raw material after above-mentioned microwave is added salting liquid by 1:4 ~ 1:6 (w/v), and puts into 100 DEG C of water-baths and heat 1-2h;
(4) enzymolysis processing: the raw material extract that step (3) is handled well is cooled to room temperature, regulates PH, adds the protease preparation of mass ratio 1.5%-3%, enzymolysis 2-4h in 40-60 DEG C of water-bath;
(5) obtained product oil: by above-mentioned enzymolysis liquid centrifugal treating, the edible vegetable oil on upper strata drawn by the supernatant obtained, and by edible vegetable oil in vacuum drying, be dried to constant weight, i.e. obtained product oil.
Preferably, above-mentioned each raw material components is: tea seed: 8 parts, fish liver: 2 parts, Semen sesami nigrum: 3 parts, grape pip: 2 parts, pumpkin: 1.5 parts, pomegranate seed: 1 part, carrot: 1 part, balsam pear: 1 part.
Preferably, after above-mentioned steps (4), by enzymolysis liquid ultrasonic wave process 10-15min.
Preferably, the protease preparation described in above-mentioned steps (4) is neutral protein enzyme preparation.
Preferably, the salting liquid in above-mentioned steps (3) is sodium chloride, potassium chloride, calcium chloride brine.
Preferably, described concentration of salt solution is concentration is 5-15g/L.
The present invention has following beneficial effect: the present invention be tea seed as base stock, auxiliary material selects fish liver, Semen sesami nigrum, grape pip, pumpkin, pomegranate seed, carrot, balsam pear, and supplementary material comprehensively extracts.Tea seed is the extraction raw material of camellia seed oil, camellia seed oil is rich in unrighted acid, also contain Tea Polyphenols, squalene etc. to active material, diabetes human body internal memory, at a large amount of free radical, thus makes vivo oxidation activity aggravation, injuries of tissues and organs is larger, old and feeble very fast and be easy to cause other syndrome of diabetes, very large threat is caused to the health of diabetes patient, thus removes interior free yl, reduce vivo oxidation material, for most important diabetes patient.Squalene have improve superoxide dismutase (SOD) in body active, strengthen body immunity, anti-ageing, Tea Polyphenols is the general name of polyphenols in tea oil, has to reduce cholesterol, anti-ageing, radioresistance, removing human free radical, have inhibiting all-natural anti-oxidant to cancer cell.Containing abundant vitamin E and vitamin B1 and unrighted acid in Semen sesami nigrum.Containing a large amount of DHA and EPA in cod-liver oil, can the atherosis angiocardiopathy such as formation and development, prevention cerebral thrombus, cerebral hemorrhage, hypertension of prevention of arterial.OPC containing abundant Green Tea Extract in grape-kernel oil and granada seed oil, antioxidation is remarkable.There is high-content linoleic acid in pumpkin, effectively can reduce blood sugar; Balsam pear extracts flavonoid substances and has the effects such as hypoglycemic, blood fat, anti-inflammatory.Carrotene has good protective effect for eyesight, and the complication of diabetes patient's retinal damage is general, and edible carrotene can prevent the generation of retinal complication.
Comprehensive nutrition of the present invention, benefit active is more, and long-term eating on the glycemic control of diabetes patient and minimizing complication, well impact can occur to produce, applicable diabetes patient.
540 diabetes patients, age distribution 50-75 year, be divided into three groups at random, respectively edible the special tea oil of the present invention, commercially available common tea oil and other edible oils, edible half a year, measure weekly blood sugar and blood pressure, monthly measure blood fat.Fact proved, edible tea oil provided by the present invention, blood sugar for human body, the blood pressure level in edible later stage are stablized, and blood lipid level reduces.Show the special tea oil of diabetes patient provided by the present invention, compared with general commercially available edible oil on the market, have very large advantage, be more applicable to diabetes patient.
Detailed description of the invention
Below by way of specific embodiment, the present invention is further described, is all included in protection scope of the present invention according to the amendment that embodiment Spirit Essence is done.
Embodiment 1:
(1) tea seed is chosen: 8 parts, fish liver: 2 parts, Semen sesami nigrum: 3 parts, grape pip: 2 parts, pumpkin: 1.5 parts, pomegranate seed: 1 part, carrot: 1 part, balsam pear: 1 part; Selected respectively by each raw material, clear up removal of impurities and dry process, dry environment is that lucifuge is dry, and baking temperature is 10 DEG C, and after dry, each material composition mixes and is crushed to the powder that granularity is 0.05mm; Low-temperature dark drying is conducive to protecting the active component in raw material, and pulverizing raw material is then to improve recovery rate.
(2) raw material microwave process: by the above-mentioned raw material handled well, put into micro-wave oven microwave 90s, microwave frequency is set to 2450MHz, and microwave treatment can improve the recovery rate of grease and other active materials;
(3) solution extracts: the raw material after above-mentioned microwave being added concentration is 10g/L sodium chloride solution, and the amount adding 4L salting liquid by 1kg raw material is added, and puts into 100 DEG C of water-baths and heat 1h, and heating water bath can effective rapid extraction;
(4) enzymolysis processing: the raw material extract that step (3) is handled well is cooled to room temperature, adjust ph is neutral, adds the neutral protein enzyme preparation of mass ratio 2%, enzymolysis 3h in 60 DEG C of water-baths, protease hydrolytic, improves grease extraction efficiency;
(5) obtained product oil: by above-mentioned enzymolysis liquid centrifugal treating, the edible vegetable oil on upper strata drawn by the supernatant obtained, and by edible vegetable oil in vacuum drying, be dried to constant weight, i.e. obtained product oil.
As shown in table 1, 60 diabetes patients and the product oil obtained by edible embodiment 1, 60 commercially available common tea oil of diabetes patient, 60 daily edible oils of diabetes patient (not comprising tea oil goods), half a year, laggard promoting circulation of blood was sugared, the conventional detection of blood pressure and triglyceride, as can be seen from testing result, compared with other edible oils commercially available, the product oil that edible embodiment 1 is obtained and commercially available common tea oil, blood sugar, blood pressure and lipids contents all decrease, and blood sugar, blood pressure stabilization, be in normal range (NR), and the effect of embodiment 1 is better than commercially available common tea oil.Known, embodiment 1 has good action for diabetes patient.
Table 1 embodiment 1 is for the impact of the part health indicator of diabetes patient
Embodiment 2:
(1) tea seed is chosen: 7 parts, fish liver: 3 parts, Semen sesami nigrum: 2 parts, grape pip: 1.5 parts, pumpkin: 2 parts, pomegranate seed: 0.5 part, carrot: 1 part, balsam pear: 1 part; Selected respectively by each raw material, clear up removal of impurities and dry process, dry environment is that low-temperature dark is dry, and baking temperature is 10 DEG C, and after dry, each material composition mixes and is crushed to the powder that granularity is 0.05mm;
(2) raw material microwave process: by the above-mentioned raw material handled well, put into micro-wave oven microwave 90s, microwave frequency is set to 2400MHz;
(3) solution extracts: the raw material after above-mentioned microwave being added concentration is 10g/L Klorvess Liquid, and the amount adding 5L salting liquid by 1kg raw material is added, and puts into 100 DEG C of water-baths and heat 1.5h;
(4) enzymolysis processing: the raw material extract that step (3) is handled well is cooled to room temperature, adjust ph is neutral, adds the neutral protein enzyme preparation of mass ratio 3%, enzymolysis 2h in 60 DEG C of water-baths;
(5) obtained product oil: by above-mentioned enzymolysis liquid centrifugal treating, the edible vegetable oil on upper strata drawn by the supernatant obtained, and by edible vegetable oil in vacuum drying, i.e. obtained product oil.
As shown in table 2, 60 diabetes patients and the product oil obtained by edible embodiment 2, 60 commercially available common tea oil of diabetes patient, 60 daily edible oils of diabetes patient (not comprising tea oil goods), half a year, laggard promoting circulation of blood was sugared, the conventional detection of blood pressure and triglyceride, as can be seen from testing result, compared with other edible oils commercially available, the product oil that edible embodiment 2 is obtained and commercially available common tea oil, blood sugar, blood pressure and lipids contents all decrease, and blood sugar, blood pressure stabilization, be in normal range (NR), and the effect of embodiment 2 is better than commercially available common tea oil.Known, embodiment 2 has good action for diabetes patient.
Table 2 embodiment 2 is for the impact of the part health indicator of diabetes patient
Embodiment 3:
(1) tea seed is chosen: 8 parts, fish liver: 2 parts, Semen sesami nigrum: 2 parts, grape pip: 2 parts, pumpkin: 2 parts, pomegranate seed: 1.5 parts, carrot: 1 part, balsam pear: 1 part; Selected respectively by each raw material, clear up removal of impurities and dry process, dry environment is that low-temperature dark is dry, and baking temperature is 10 DEG C, and after dry, each material composition mixes and is crushed to the powder that granularity is 0.05mm;
(2) raw material microwave process: by the above-mentioned raw material handled well, put into micro-wave oven microwave 100s, microwave frequency is set to 2500MHz;
(3) solution extracts: the raw material after above-mentioned microwave being added concentration is 15g/L calcium chloride solution, and the amount adding 5L salting liquid by 1kg raw material is added, and puts into 100 DEG C of water-baths and heat 2h;
(4) enzymolysis processing: the raw material extract that step (3) is handled well is cooled to room temperature, adjust ph is neutral, adds the neutral protein enzyme preparation of mass ratio 2%, enzymolysis 4h in 50 DEG C of water-baths;
(5) obtained product oil: by above-mentioned enzymolysis liquid centrifugal treating, the edible vegetable oil on upper strata drawn by the supernatant obtained, and by edible vegetable oil in vacuum drying, i.e. obtained product oil.
As shown in table 3, 60 diabetes patients and the product oil obtained by edible embodiment 3, 60 commercially available common tea oil of diabetes patient, 60 daily edible oils of diabetes patient (not comprising tea oil goods), half a year, laggard promoting circulation of blood was sugared, the conventional detection of blood pressure and triglyceride, as can be seen from testing result, compared with other edible oils commercially available, the product oil that edible embodiment 3 is obtained and commercially available common tea oil, blood sugar, blood pressure and lipids contents all decrease, and blood sugar, blood pressure stabilization, be in normal range (NR), and the effect of embodiment 3 is better than commercially available common tea oil.Known, embodiment 3 has positive impact for diabetes patient.
Table 3 embodiment 3 is for the impact of the part health indicator of diabetes
Facts have proved, the tea oil that the present invention obtains is applicable to diabetes patient.
Embodiment 4:
(1) tea seed is chosen: 5 parts, fish liver: 2 parts, Semen sesami nigrum: 3 parts, grape pip: 2.5 parts, pumpkin: 2 parts, pomegranate seed: 1.2 parts, carrot: 1 part, balsam pear: 1 part; Selected respectively by each raw material, clear up removal of impurities and dry process, dry environment is that low-temperature dark is dry, and baking temperature is 10 DEG C, and after dry, each material composition mixes and is crushed to the powder that granularity is 0.05mm;
(2) raw material microwave process: by the above-mentioned raw material handled well, put into micro-wave oven microwave 100s, microwave frequency is set to 2450MHz;
(3) solution extracts: the raw material after above-mentioned microwave being added concentration is 15g/L calcium chloride solution, and the amount adding 4.5L salting liquid by 1kg raw material is added, and puts into 100 DEG C of water-baths and heat 2h;
(4) enzymolysis processing: the raw material extract that step (3) is handled well is cooled to room temperature, adjust ph is neutral, adds the neutral protein enzyme preparation of mass ratio 2%, enzymolysis 4h in 50 DEG C of water-baths;
(5) obtained product oil: by above-mentioned enzymolysis liquid centrifugal treating, the edible vegetable oil on upper strata drawn by the supernatant obtained, and by edible vegetable oil in vacuum drying, i.e. obtained product oil.
As shown in table 3, 40 diabetes patients and the product oil obtained by edible embodiment 4, 10 commercially available common tea oil of diabetes patient, 10 diabetes patient comparative example 1 tea oil (make raw material identical with embodiment 4, only microwave frequency is set to 2000MHz), 10 diabetes patient comparative example 2 tea oil (make raw material identical with embodiment 4, only microwave frequency is set to 2800MHz), half a year, laggard promoting circulation of blood was sugared, the conventional detection of blood pressure and triglyceride, as can be seen from testing result, compared with the group of edible comparative example tea oil, the group of the product oil that edible embodiment 4 is obtained and commercially available common tea oil, blood sugar, blood pressure and lipids contents all decrease, and blood sugar, blood pressure stabilization, be in normal range (NR), and the effect of embodiment 4 is better than commercially available common tea oil.
Table 4 embodiment 4 is for the impact of the part health indicator of diabetes
Visible, the microwave frequency of 2400-2500MHz has the adjection promoting its activity to raw material.Although mechanism is also indefinite, inferring may to accelerate the cohesion speed of the active material in material powder relevant with the microwave energy of this frequency range, or to cause the desorption of some polar molecule relevant with microwave.
The foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, for a person skilled in the art, the present invention can have various modifications and variations.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (6)
1. the tea oil that diabetes patient is special, is characterized in that, is prepared from by following raw materials according:
Tea seed: 5-8 part, fish liver: 2-3 part, Semen sesami nigrum: 2-3 part, grape pip: 1-2.5 part, pumpkin: 1-2 part, pomegranate seed: 0.5-1.5 part, carrot: 0.5-1 part, balsam pear: 0.5-1 part;
Its preparation method is:
1) raw material pre-treatment: selected respectively by above-mentioned raw materials, clear up removal of impurities and dry process, dry environment is that lucifuge is dry, and baking temperature is no more than 20 DEG C, and after dry, each material composition mixes and is crushed to Powdered, and particle diameter is not more than 0.15mm;
2) raw material microwave process: by the above-mentioned raw material handled well, put into micro-wave oven microwave 90-110s, microwave frequency is set to 2400-2500MHz;
3) solution extracts: the raw material after above-mentioned microwave is added salting liquid by 1:4 ~ 1:6 (w/v), and puts into 100 DEG C of water-baths and heat 1-2h;
4) enzymolysis processing: by step 3) the raw material extract handled well is cooled to room temperature, adds the protease preparation of mass ratio 1.5%-3%, enzymolysis 2-4h in 40-60 DEG C of water-bath;
5) obtained product oil: by above-mentioned enzymolysis liquid centrifugal treating, draw the edible vegetable oil on upper strata from the supernatant obtained, and by edible vegetable oil in vacuum drying, be dried to constant weight, i.e. obtained product oil.
2. the tea oil that diabetes patient as claimed in claim 1 is special, is characterized in that above-mentioned raw materials component is: tea seed: 8 parts, fish liver: 2 parts, Semen sesami nigrum: 3 parts, grape pip: 2 parts, pumpkin: 1.5 parts, pomegranate seed: 1 part, carrot: 1 part, balsam pear: 1 part.
3. the tea oil that diabetes patient as claimed in claim 1 is special, is characterized in that above-mentioned steps 4) after, by enzymolysis liquid ultrasonic wave process 10-15min.
4. the tea oil that diabetes patient as claimed in claim 1 is special, is characterized in that step 4) described in protease preparation be neutral protein enzyme preparation.
5. the tea oil that diabetes patient as claimed in claim 1 is special, is characterized in that the salting liquid in above-mentioned steps (3) is sodium chloride, potassium chloride, calcium chloride brine.
6. the tea oil that diabetes patient as claimed in claim 5 is special, is characterized in that the concentration of described salting liquid is 5-15g/L.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510487743.0A CN105010579A (en) | 2015-08-11 | 2015-08-11 | Tea oil special for diabetes patients and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510487743.0A CN105010579A (en) | 2015-08-11 | 2015-08-11 | Tea oil special for diabetes patients and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105010579A true CN105010579A (en) | 2015-11-04 |
Family
ID=54401227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510487743.0A Pending CN105010579A (en) | 2015-08-11 | 2015-08-11 | Tea oil special for diabetes patients and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105010579A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105901176A (en) * | 2016-04-15 | 2016-08-31 | 安徽华安食品有限公司 | Mixed oil specially used for patients with diabetes and a preparing method thereof |
| CN106070737A (en) * | 2016-08-18 | 2016-11-09 | 贵州石阡佛顶山野生油茶油业有限公司 | A kind of special Oleum Camelliae and preparation method thereof of losing weight |
| CN109938116A (en) * | 2019-04-01 | 2019-06-28 | 湖南康琪壹佰生物科技有限公司 | A kind of pumpkin seed oil and preparation method thereof improving prostatic function |
| CN111471514A (en) * | 2020-04-13 | 2020-07-31 | 湖南润农生态茶油有限公司 | Preparation method and application of tea oil rich in trace elements |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101967423A (en) * | 2010-11-05 | 2011-02-09 | 南昌大学 | Method for extracting tea oil by microwave-assisted aqueous enzymatic method |
| CN102106411A (en) * | 2011-01-21 | 2011-06-29 | 南昌大学 | Nutrient oil for diabetics |
| CN102952624A (en) * | 2012-11-06 | 2013-03-06 | 安徽新世界绿洲茶油有限公司 | Preparation process for strong-flavor tea-seed oil and prepared strong-flavor tea-seed oil |
| CN103254989A (en) * | 2012-02-15 | 2013-08-21 | 河源市绿康生态农业科技有限公司 | Method for extraction of tea seed oil by ultrasound-assisted enzymatic process |
| CN103444911A (en) * | 2012-06-05 | 2013-12-18 | 张伟伟 | Medicinal and edible health care blending oil |
| CN103555412A (en) * | 2013-11-06 | 2014-02-05 | 福建明溪恒香油茶开发有限公司 | Method for extracting tea-seed oil |
| CN103651945A (en) * | 2013-11-22 | 2014-03-26 | 安徽大平油脂有限公司 | Health oil with efficacy of promoting blood circulation to remove meridian obstruction |
| CN104450152A (en) * | 2013-09-23 | 2015-03-25 | 贵州周以晴生物科技有限公司 | Compound technology for extracting tea seed oil employing aqueous enzymatic method |
| CN104719511A (en) * | 2015-03-25 | 2015-06-24 | 江西绿源油脂实业有限公司 | Tea oil capable of regulating blood sugar and preparation method of tea oil |
-
2015
- 2015-08-11 CN CN201510487743.0A patent/CN105010579A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101967423A (en) * | 2010-11-05 | 2011-02-09 | 南昌大学 | Method for extracting tea oil by microwave-assisted aqueous enzymatic method |
| CN102106411A (en) * | 2011-01-21 | 2011-06-29 | 南昌大学 | Nutrient oil for diabetics |
| CN103254989A (en) * | 2012-02-15 | 2013-08-21 | 河源市绿康生态农业科技有限公司 | Method for extraction of tea seed oil by ultrasound-assisted enzymatic process |
| CN103444911A (en) * | 2012-06-05 | 2013-12-18 | 张伟伟 | Medicinal and edible health care blending oil |
| CN102952624A (en) * | 2012-11-06 | 2013-03-06 | 安徽新世界绿洲茶油有限公司 | Preparation process for strong-flavor tea-seed oil and prepared strong-flavor tea-seed oil |
| CN104450152A (en) * | 2013-09-23 | 2015-03-25 | 贵州周以晴生物科技有限公司 | Compound technology for extracting tea seed oil employing aqueous enzymatic method |
| CN103555412A (en) * | 2013-11-06 | 2014-02-05 | 福建明溪恒香油茶开发有限公司 | Method for extracting tea-seed oil |
| CN103651945A (en) * | 2013-11-22 | 2014-03-26 | 安徽大平油脂有限公司 | Health oil with efficacy of promoting blood circulation to remove meridian obstruction |
| CN104719511A (en) * | 2015-03-25 | 2015-06-24 | 江西绿源油脂实业有限公司 | Tea oil capable of regulating blood sugar and preparation method of tea oil |
Non-Patent Citations (4)
| Title |
|---|
| 刘瑞兴等: "水酶法提取油茶籽油的工艺优化及其营养成分分析", 《中国粮油学报》 * |
| 施仁潮等: "《慢性病防治200问》", 30 April 2014, 浙江大学出版社 * |
| 赵霖: "具有保健作用的特色食用油", 《健康指南》 * |
| 邓修: "《中药制药工程与技术》", 31 May 2008, 华东理工大学出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105901176A (en) * | 2016-04-15 | 2016-08-31 | 安徽华安食品有限公司 | Mixed oil specially used for patients with diabetes and a preparing method thereof |
| CN106070737A (en) * | 2016-08-18 | 2016-11-09 | 贵州石阡佛顶山野生油茶油业有限公司 | A kind of special Oleum Camelliae and preparation method thereof of losing weight |
| CN109938116A (en) * | 2019-04-01 | 2019-06-28 | 湖南康琪壹佰生物科技有限公司 | A kind of pumpkin seed oil and preparation method thereof improving prostatic function |
| CN111471514A (en) * | 2020-04-13 | 2020-07-31 | 湖南润农生态茶油有限公司 | Preparation method and application of tea oil rich in trace elements |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104255977B (en) | A kind of radioprotective milk vinegar green-tea health-care beverage | |
| CN105296584A (en) | Preparation method of marine biological health care peptide preparation | |
| KR101033667B1 (en) | Manufacturing method of eel soup using ripening dried radish leaves and health-supporting food using the same | |
| CN105010579A (en) | Tea oil special for diabetes patients and preparation method thereof | |
| CN105412623A (en) | Medicament for treating fatty liver, prostatitis, nephralgia, nephritis, hypertension and diabetes | |
| CN104840612A (en) | Low-sugar tea oil emulsion | |
| CN103082034A (en) | Health-care blend oil | |
| CN102511881A (en) | Thickened pulp containing walnuts and red jujubes | |
| CN102754767A (en) | Blood sugar-lowering loach noodles and preparation method thereof | |
| CN103082267B (en) | Tomato chili sauce with function of removing cardiopyrexia for tranquilization and preparation method for tomato chili sauce | |
| CN103610077A (en) | Sea cucumber capsule | |
| CN102669598B (en) | Vigour raising paste containing Rosa roxburghii Tratt | |
| US20160199429A1 (en) | Astragalus membranaceus seed raw oil, refined oil, preparation method therefor and use thereof | |
| CN104413169A (en) | Tea-seed oil-based fortified food balanced in omega-3, omega-6 and omega-9 fatty acids | |
| CN108200973A (en) | A kind of reducing blood pressure and blood fat camellia oil and its processing method | |
| CN101361864B (en) | Natural cordyceps sinensis oil | |
| CN103766507A (en) | Edible oil with health-care function | |
| CN107495297B (en) | Processing method of ham sauce | |
| CN106035749A (en) | Health-care fruit-flavored cottonseed blend oil | |
| CN109430847A (en) | A kind of tea oil soft capsule and preparation method thereof | |
| CN103222626B (en) | Compound sea cucumber capsule and preparation method thereof | |
| CN105192767A (en) | Process for making sea-buckthorn and walnut sauce | |
| CN104206542B (en) | A kind of red date milk body-building drink | |
| CN103960565A (en) | Black kidney bean nutritious bean vermicelli | |
| CN103610068A (en) | Preparation method for blood-fat-reducing sea cucumber oral liquid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151104 |
|
| RJ01 | Rejection of invention patent application after publication |